Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Triamcinolone Acetonide + Fluconazole vs Topical Mometasone Furoate + Miconazole Nitrate for Chronic Paronychia
NCT07311759Phase 3Active, not recruiting
- Sponsor
- Cairo University
- Start
- Aug 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone acetonide, fluconazole in paronychia, sponsored by Cairo University. Started Aug 2024; status: active, not recruiting.
02
Drugs
triamcinolone acetonidefluconazole
03
Conditions
paronychia
Beyond the preview
Go deeper on NCT07311759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07311759.